Introduction
Jun belongs to the AP-1 family of sequence-speci®c transcriptional regulators (Bohmann et al., 1987; Bos et al., 1988; Karin et al., 1997) . These proteins share structural and functional features characteristic of bZip proteins (Landschulz et al., 1988) : a leucine zipper mediating dimerization and an adjacent basic region responsible for DNA contact. Although Jun can homodimerize, it forms more stable heterodimers with the AP-1 protein Fos, with close relatives of Fos, and with members of the activating transcription factor (ATF) family. Jun-Jun and Jun-Fos dimers preferentially bind to the DNA sequence TGACTCA (TPAresponsive element; TRE), whereas Jun-ATF or ATF homodimers prefer to bind TGACGTCA (cAMPresponsive elements; CRE). Dierent Jun-containing dimers thus regulate distinct targets and induce diverse biological functions (Karin et al., 1997; van Dam et al., 1998) . The highly oncogenic viral form of Jun (v-Jun) recovered from avian sarcoma virus 17 (ASV 17) diers from its cellular progenitor (c-Jun) by a 27-amino acid internal deletion in the amino-terminal transactivation domain and two amino acid substitutions in the carboxyl-terminal DNA binding/dimerization domain (Nishimura and Vogt, 1988) . The aminoterminal deletion prevents the phosphorylation of vJun by the Jun kinase JNK (Hibi et al., 1993) , which controls transcriptional regulation by c-Jun. The two amino acid substitutions aect DNA-binding of Jun (Abate et al., 1990; Boyle et al., 1991) . All of these mutations cooperate to activate the oncogenic transforming potential of Jun (Morgan et al., 1993 (Morgan et al., , 1994 .
Oncogenic transformation induced by v-Jun probably results from the deregulation of speci®c target genes. However, there is no simple correlation between the transcriptional activation potential of Jun mutants as measured at the consensus TRE site and their oncogenic activity (Havarstein et al., 1992; Oliviero et al., 1992) . On TRE-controlled promoters, v-Jun is a less ecient transactivator than c-Jun; it also suppresses transactivation by c-Jun. In contrast, on a promoter with a CRE-like binding site, v-Jun is the more potent. Therefore, v-Jun and c-Jun may dierentially interact with promoter sequences (Gao et al., 1996; Hussain et al., 1998) . Further insights into the mechanism of v-Jun transformation will develop from the identi®cation and functional characterization of aberrantly expressed target genes. Previous eorts have identi®ed several upregulated v-Jun targets including quail bkj, encoding a member of the b-keratin family, chicken jtab-1, encoding a cathepsin-like protein and the genes encoding glutaredoxin, neuromodulin, phenobarbital-induced cytochrome P450 and heparinbinding EGF-like growth factor (HB-EGF) (Fu et al., 1999; Goller et al., 1998; Hadman et al., 1996; Hartl and Bister, 1995) . One of these targets, HB-EGF, can induce partial oncogenic transformation. Transformation probably requires the aberrant regulation of more than one relevant gene, and not all genes that are dierentially expressed in transformed cells will be necessary participants of the transformation process. Target identi®cation and characterization therefore remain important tasks. In this report we describe new targets of viral Jun and their functions.
al., 1998; Usui et al., 1994) . The subtractive library was screened by hybridization to cDNA probes from RCAS(A) vector-infected CEF (driver), and from RCAS(A)VJ0 transformed CEF (target) resulting in the identi®cation of 48 dierentially expressed clones. They show hybridization to target probes and probes from the subtractive library, but fail to hybridize to driver probes and probes representing previously identi®ed targets. Twenty-four clones with a pronounced dierential hybridization were then tested in Northern blots with poly(A) RNA from vector-infected or v-Jun-transformed CEF in order to con®rm dierential expression and determine the size of the corresponding mRNA. Six clones were strongly upregulated by v-Jun; they are referred to as viral Jun targets (VJTs) (Figure 1 ).
Sequence analysis of v-Jun target genes
Full length or nearly full-length clones of the VJTs except VJT-2 were obtained from the two cDNA libraries described in the Materials and methods section. VJT-2 and VJT-35 do not show homology to known proteins. For VJT-11, VJT-14, VJT-15 and VJT-22 the predicted translation products which contain apparent complete open reading frames show homology to sequences in the database (Table 1) . VJT-11 is related to a protein of unknown function encoded by R53.5 of C. elegans, VJT-14 is homologous to cytokine-inducible SH2-containing proteins (CIS) (also called suppressors of cytokine signaling (SOCS)), VJT-15 is the avian homolog of the reversion-induced LIM protein (RIL), and VJT-22 is closely related to the mitogen-activated protein kinase phosphatase 2 (MKP-2). The translation product of VJT-14, coding for the chicken CIS is a 249 amino-acid protein with extensive homology to mouse CIS 1 (overall 68%) at the amino acid level, especially at the internal SH2 (Src homology 2) domain (86% identity) and carboxyl-terminal CH (CIS homology) domain (56% identity) (Figure 2 ). Chicken RIL encoded by VJT-15 is a 330 amino-acid protein and shows 60% overall homology to human RIL at the amino acid level (Figure 3a) . The homology is particularly high at the amino-terminal PDZ motif (77% identity) and at the carboxyl-terminal LIM domain (86% identity). The potential tyrosine phosphorylation site within the LIM domain is also conserved (Figure 3b ). Chicken MKP-2, a 375 amino acid protein, shows 85% identity to human MKP-2 at the amino acid level, including a conserved catalytic site of typical phosphatase. In vitro transcription/ translation of the full-length RIL and MKP-2 both gave single peptides consistent with the predicted protein sizes (data not shown).
Kinetics of v-Jun target expression
Dierentially expressed genes in Jun-transformed CEF should include both necessary mediators of the transformed phenotype and genes that are irrelevant to the transformation process. The estrogen-regulatable Jun construct DVJ-hER consisting of the carboxyl terminal half of Jun fused to the hormone-binding domain of the human estrogen receptor was used to eliminate targets that are unlikely to play a role in transformation. Addition of estrogen to normal CEF producing the DVJ-hER chimeric protein results in full transformation but a v-Jun responsive reporter is only weakly activated by DVJ-hER in the presence of estrogen (Kruse et al., 1997) . DVJ-hER may, therefore, Similarly, VJT-11 shows increased expression in vJun-transformed CEF but is not upregulated in DVJhER CEF in the presence of estrogen (data not shown). The remaining VJTs were variously induced by estrogen-activated v-Jun. VJT-35 shows early induction at 1 h (twofold) which is sustained for 12 h. MKP-2 was transiently activated with a peak at 1 h (eightfold) followed by a decrease to threefold induction. The rapid induction of MKP-2 and VJT-35 suggests they may be primary targets whose promoters interact with Jun. The induction of CIS is delayed with a small detectable increase at 2 h, further rising to threefold by 12 h. RIL was tightly induced by Jun. In the absence or presence of estrogen, RIL expression was low in CEF transfected with the hER control vector but high in wild type v-Jun transformed cells ( Figure 4a ). Upon adding estrogen to DVJ-hERexpressing CEF, RIL expression increased at 6 h (fourfold) and reached maximum expression at 12 h (eightfold), a level comparable to that in v-Jun transformed CEF (VJ1-CEF). In CEF transfected with DVJ-hER, the regulation of RIL was dependent on Jun activity: in the presence of estrogen, RIL mRNA levels were elevated. Withdrawal of estrogen almost completely reversed this eect within 48 h ( Figure 4b ). Estrogen did not exert any signi®cant eects on negative or positive controls ( Figure 4b , lanes 1 ± 6). These data suggest that RIL expression re¯ects the transformation status of v-Jun expressing CEF, providing a molecular marker for monitoring transformation.
Transforming potential of Jun mutants and induction of VJTs
The oncogenic transforming potential of Jun mutants extends from high, comparable to that of wild type v- Figure 2 Alignment of the putative chicken CIS protein to mouse CIS1. The alignment was generated with the ClustalW program. Identical amino acid residues are highlighted. The mouse CIS 1 protein sequence was downloaded from the PIR protein database (accession number=S55551). The SH2 domain is marked with inverted arrows. The putative CH domain is boxed Jun, to zero. With such mutants the relationship of transformation to the induction of VJTs was examined. Mutants CJ3-34 and AVCJ3 are strongly transforming, similar to v-Jun (Havarstein et al., 1992; Schuur et al., 1993) . CJ3 and CJ3-23 are weakly transforming, generating less than 20% of the number of foci/unit DNA induced by v-Jun (Havarstein et al., 1992) . JunDLZ and VJ-3 are nontransforming deletion mutants from the carboxyl or amino terminus, respectively (Morgan et al., , 1994 . These mutants were expressed in CEF with the RCAS vector, and the regulation of VJTs in these cells was determined by Northern blotting ( Figure 5 ). Protein expression of each Jun mutant was con®rmed by Western blot using a Jun-speci®c antibody (data not shown). The expression of MKP-2, CIS and VJT-35 did not correlate with the transforming potential of the mutants. MKP-2 was only slightly activated by the strongly transforming mutant CJ-34 but was moderately expressed in CEF infected with non-transforming VJ-3 (threefold higher than control). CIS is only weakly activated by AVCJ3, a strongly transforming construct. VJT-35 is activated by the non-transforming Jun constructs JUNDLZ and VJ3 but is unresponsive to the highly transforming CJ3-34. RIL expression correlated with the transforming potential of each construct: It was high in CEF expressing the strongly-transforming VJ0, CJ3-34 and AVCJ3, moderate in CEF expressing weakly transforming CJ3 and CJ3-23 and low in non-transforming RCAS(A), VJ3 and JUNDLZ. Of the VJTs described here, RIL is the best candidate for a transformationrelevant gene. CEF infected with hER, VJ1 or DVJ-hER were treated with estrogen according to the following schedule:`7', 10 ml ethanol for 48 h;`+', 2 mM estrogen (in 10 ml ethanol) for 48 h;`+', 48 h of estrogen followed by 48 h without estrogen. Twenty mg of total RNA from each cell type were used in Northern blot analysis, and probed with a DNA fragment from either RIL or GAPDH Figure 5 Northern blots showing expression of selected VJTs in CEF transfected with various Jun mutants. Twenty mg RNA from mutant infected and control were electrophoresed, blotted and probed with the indicated VJT or with GAPDH. The transforming potential of the mutants is divided into three categories: ++, actively transforming constructs with focus-forming activity (number/mg DNA) equal to or higher than v-Jun . +, weakly transforming mutants with 5 ± 15% focus forming activity. 7, non-transforming mutants their aberrant growth behavior. We therefore compared the expression of VJTs in CEF transformed by various retroviral oncoproteins (Figure 6 ). None of the VJTs is v-Jun speci®c. RIL was induced by the bZip proteins Jun and Fos, but downregulated by Maf, Myc, Src, Mos, and Fps. The expression of RIL in Ras, P3k and Crk transformed cells was comparable to that observed in CEF. MKP-2 is upregulated by Jun, Src and Mos. The most prominent induction of CIS was observed in Src transformed CEF. An elevated transcript level could be detected in CEF transformed by Jun, P3k, Crk, Fps, Ras and Myc but not in Fos transformed CEF. VJT35 was upregulated in Jun expressing CEF and downregulated in CEF transformed by Fos, Maf, Myc, Ras, Src, P3k and Mos. RIL was also tested for a possible eect on the phenotype of normal CEF. The protein was linked to an in¯uenza virus hemagglutinin (HA) tag for immune detection and was over-expressed in CEF with the RCAS vector. Expression was veri®ed by Western blotting using anti-hemagglutinin antibody. The RILexpressing cells did not show a detectable change in morphology or growth behavior (data not shown).
Expression of VJTs in CEF transformed by various oncogenes

Discussion
The directional tag PCR technique yielded numerous clones that dierentially hybridize to cDNA from Juntransformed as compared to vector control CEF. Six of these clones were selected for further study. Three represent unknown genes, and three are homologs of mammalian genes: CIS-1, MKP-2, and RIL. CIS proteins are stimulated by cytokines and act in a feed back loop regulating cytokine signaling (Yoshimura, 1998; Yoshimura et al., 1995) . They interact with the cytoplasmic domains of cytokine receptors or with Janus kinases and inhibit the Jak/STAT pathway. MKP-2 is a dual speci®c threonine-tyrosine phosphatase (MisraPress et al., 1995) . In mammalian cells, activation of MAP kinase leads to an induction of MKP-2 (Brondello et al., 1997) . Overexpression of MKP-2 inhibits MAP kinase signaling, MKP-2 also blocks the activation of the MAP kinase target c-Jun (Hirsch and Stork, 1997). The mammalian version of RIL was originally cloned from revertants of H-Ras transformed rat FE-8 cells (Kiess et al., 1995) . Transformation by H-Ras downregulates RIL in rat cells; in CEF, RIL is not aected by Ras-induced transformation. CIS, MKP-2 and RIL can be considered as bona ®de negative regulators of cell growth. Their upregulation in Jun-transformed cells therefore comes as a surprise. The enhanced expression of these mRNAs may re¯ect cellular homeostatic mechanisms that are triggered by the increased activity of positive regulators. Feedback loops enhancing the expression of negative regulators may become operative but in the end fail to control the growth stimulatory eects of the oncogene. Alternatively, CIS, MKP-2 and RIL may not function as negative growth regulators in Jun-transformed cells but may be components of novel transforming pathways. This possibility is suggested by the association of MKP with human cancer. MKP-2 is highly expressed in hepatomas but nearly undetectable in normal liver cells (Yokoyama et al., 1997) .
RIL is the most interesting of the new targets. It carries a PDZ and a LIM domain at the amino and carboxyl terminus respectively (Dawid et al., 1998; Fanning and Anderson, 1998; Jurata and Gill, 1998; Ranganathan and Ross, 1997) . Both domains are protein-protein interaction motifs. A relative of RIL, the protein termed Enigma, functions as adaptor molecule, mediating the assembly of multiprotein complexes and coupling cell surface receptors to downstream components of cell signaling Guy et al., 1999; Wu et al., 1996) . The PDZ motif of RIL has been shown to bind the protein phosphatase PTP-BL as well as the LIM domain of RIL itself (Cuppen et al., 1998) . The LIM domain of RIL can be phosphorylated both in vivo and in vitro. These data suggest that RIL may interact with other proteins, possibly functioning as an adaptor molecule. As seen with the oncogenic adaptor Crk, such molecules can disturb cellular growth regulation and can induce oncogenic transformation. Dominant negative mutants of RIL could provide further insights into the function of this protein.
Several techniques have been designed for the identi®cation of dierentially expressed genes, including dierential display, cDNA-based RDA, directional tag PCR, SABRE, SAGE and, more recently, DNA microarrays (DeRisi et al., 1996; Hubank and Schatz, 1994; Lavery et al., 1997; Liang and Pardee, 1992; Usui et al., 1994; Velculescu et al., 1995) . These techniques have the potential of yielding extensive and comprehensive lists of genes that are up-or downregulated in cancer cells as compared to normal cells. Some of these genes will be necessary participants in the oncogenic transformation process; others will be innocent bystanders. In this study, three techniques were used to screen out unimportant genes. (1) The initial selection chose genes that show the highest dierence in expression between normal and transformed cells. This is a reasonable criterion, but there is admittedly no evidence that all essential transforming genes will be in this category.
Genes showing minor dierences in expression need to be considered in future studies. (2) A hormone regulated Jun construct was used to test for correlation between activation of Jun and induction of targets. The regulated Jun is a weak transactivator, and at the same time it transforms eciently. The fact that some targets are not aected by this construct suggests that it addresses a narrower spectrum of genes that contains the essential mediators of transformation. Therefore this construct can be used to eliminate non-essential genes. (3) A correlation between transformation and upregulation of targets was also sought in a series of Jun mutants with varying transformation potential. Results from this correlation should, however, be considered with caution. It is quite possible that some non-transforming mutants upregulate some but not all essential transforming targets and that certain highly transforming mutants induce only slight changes in the expression of important genes but that these changes are sucient for transformation. In the present study, the only gene that unequivocally passes all three screens as transformation-related is RIL. However, CIS, MKP-2, and VJT-35 may still be signi®cant players if the degree of upregulation required for these genes is low. It will be interesting to test the new targets with two recently described leucine zipper mutants of Jun. One of these binds preferentially to Fos and induces foci of transformed cells in monolayer. The other binds to ATF-2 and stimulates anchorage-independent growth (van Dam et al., 1998) . These mutants could associate targets with either focus formation or anchorageindependent growth or both. Ultimately, functional tests will be required to establish and de®ne the role of a target gene in the transformation process. RIL has no detectable eect on the shape and growth behavior of CEF if overexpressed as a single gene, and preliminary tests suggest that CIS as well as MKP-2 also fail to aect cell morphology and replication. However, there may be eective combinations of two or more target genes, and experiments to test this possibility are in progress.
Materials and methods
Subtractive hybridization
The directional tag PCR subtraction method was used to generate a library of cDNA clones enriched in genes that are overexpressed in v-Jun transformed CEF (Goller et al., 1998; Usui et al., 1994) . Two directional cDNA libraries were produced in dierent vectors. The driver library originated from poly(A) + RNA of CEF transfected with the RCAS vector; the target library was constructed with poly(A) + RNA of v-Jun transformed CEF. The target cDNA contained tag sequences at the 5' and 3' ends used for PCR ampli®cation after subtraction. For subtractive hybridization, the libraries were transcribed into sense RNA, and the sense RNA of the target library was reverse transcribed into antisense cDNA. This cDNA was hybridized to the driver sense RNA, and unhybridized cDNA was selected with a hydroxylapatite column, PCR ampli®ed and cloned into the pZero-2 vector.
Plasmids and viruses
All Jun constructs have been described previously and are listed in Table 2 : the v-Jun expression plasmids RCAS(A)VJ0 and RCAS(A)VJ1, the c-Jun expression construct RCA-S(A)CJ3 (Bos et al., 1990) , the Jun-estrogen receptor chimera RCAS(A)DVJ-hER and the control plasmid RCAS(A)hER (Kruse et al., 1997) , the v-Jun deletion mutant RCAS(A)VJ3 (Morgan et al., 1993) , the c-Jun deletion mutants RCA-S(A)CJ3-23, RCAS(A)CJ3-34, and RCAS(A)JUNDLZ (Havarstein et al., 1992; Morgan et al., 1992) , and the VP16-cJun fusion RCAS(A)AVCJ3 (Schuur et al., 1993) . Retroviruses carrying various oncogenes were either naturally occurring or recombinant viruses created by inserting the oncogene into the retroviral vector RCAS(A). These viruses include ASV17 (v-jun) (Maki et al., 1987) , NK24 (v-fos) (Nishizawa et al., 1987) , PR-A (v-src) (Du and Vogt, 1969) , MC29 (v-myc) (Duesberg et al., 1977; Vogt et al., 1981) , PRCII (v-fps) , ASV1 (v-crk) (Tsuchie et al., 1989) , RCAS(A)Mos (Schmidt et al., 1988) , RCAS(A)v-P3k expressing the oncogenic version of the p110 subunit of PI 3-kinase (Chang et al., 1997) , RCAS(A)v-MafQ5H carrying a gain of function mutant of the v-maf oncogene (Kataoka et al., 1993) and RCAS(A)v-H-Ras expressing the Harvey ras gene (Antczak and Kung, 1990) .
Cell culture
Primary CEF were prepared as described previously from embryos supplied by SPAFAS (Preston, CT) (Vogt, 1969) . CEF expressing speci®c exogenous genes were obtained after standard DMSO transfection or infection with infectious retroviral vectors (Kawai and Nishizawa, 1984) . Transfected or infected CEF were maintained in F-10 medium supplemented with 10% donor calf serum, 4% chicken serum, 16minimal essential medium vitamins, 2 mM L-glutamine, 100 units/ml penicillin, 100 mg/ml streptomycin, 8 mg/ml folic acid and 0.4% DMSO. 
Northern blots
Total RNA was isolated using the RNA STAT-60 reagent (Tel-Test, Friendswood, TX, USA). Poly(A) + RNA was further puri®ed with oligotex beads (Qiagen). The RNA was then separated on 1% formaldehyde-agarose gels and blotted onto Hybond-N nylon membranes (Amersham). Hybridization and autoradiography were performed according to standard procedures. To prepare radioactive hybridization probes, puri®ed cDNA fragments were labeled with a-32 P-dCTP using a random priming kit (Boehringer Mannheim) and puri®ed with a nucleotide removal kit (Qiagen). For hybridization, the activity of the probes was from 1 ± 3610 6 c.p.m. per ml of hybridization buer. The signals were scanned with an S-12 scanner (Umax), saved as picture ®les and quanti®ed with a phosphoimager (Molecular Dynamics).
Screening of cDNA libraries
Selected clones identi®ed from a subtractive library were used as probes to isolate full-length cDNAs by screening two cDNA libraries, which were constructed by cloning the cDNA population derived from v-Jun transformed CEF into the pT7T3D plasmid vector or the Uni-ZAP XR l phage vector (Fu et al., 1999; Goller et al., 1998) . For screening, the plasmid cDNA library was transformed into XL-1 blue cells, and bacterial colonies were transferred onto Hybond-N ®lters, while phage plaques from the l cDNA library were transferred onto Hybond-C extra nitrocellulose ®lters (Amersham). Colonies on Hybond-N ®lters were lysed with 5% SDS/26sodium chloride/sodium citrate (SSC) for 2 min, heated for 3 min in a microwave (650 W), then washed with 56SSC/0.1% SDS. Hybond-C ®lters with phage plaques were treated with 1.5 M NaCl/0.5 M NaOH for two min, submerged in 1.5 M NaCl/0.5 M Tris (pH 7.5) for 5 min, washed with 26SSC/0.5 M Tris (pH 7.5), followed by baking at 808C for 2 h. Hybridizations of primary, secondary and tertiary screenings were carried out in Hood buer (50% formaldehyde, 56SSC, 20 mM sodium phosphate, pH 6.7, 7% SDS, 1% polyethylene glycol (MW 20 000), 100 mg/ml salmon testis DNA, and 5 mg/ml bovine albumin) at 428C overnight with a probe activity of 5610 5 to 10 6 c.p.m./ml. After hybridization, ®lters were washed three times for 20 min with 0.16SSC/0.1% SDS at 608C, followed by autoradiography. In vivo excisions of the pBluescript phagemids from l Uni-ZAP XR phages with positive clones were performed to obtain plasmids carrying corresponding inserts according to the supplier's protocol (Stratagene). Plasmids from all positive colonies were isolated and sequenced using a model 310 Genetic Analyzer from ABI. Homology of each nucleotide sequence was determined by BLAST database search programs (NCBI). Analysis of nucleotide and protein sequences was performed using MacVector programs (Oxford Molecular).
